Profile
General Information
Ceftin (Cefuroxime axetil) has been approved by the U.S. Food and Drug Administration for the treatment of secondary bacterial infections of acute bronchitis with 5-day therapy.
Approval Date: 1997-09-01
Date Created: 1997-10-08 12:00:00
Company Name: GlaxoSmithKline
